Raltegravir

Paul A. Pham, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D.
Raltegravir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of HIV-1 infection in combination with other ARV agents in ART-experienced pts with evidence of HIV replication despite ongoing ART.
  • Treatment of HIV-1 infection in combination with other ARV agents in ART-naive pts.

NON-FDA APPROVED USES

  • Substitution for other ARV agents due to drug toxicity or intolerance in pts on suppressive regimen (limited data)

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Treatment of HIV-1 infection in combination with other ARV agents in ART-experienced pts with evidence of HIV replication despite ongoing ART.
  • Treatment of HIV-1 infection in combination with other ARV agents in ART-naive pts.

NON-FDA APPROVED USES

  • Substitution for other ARV agents due to drug toxicity or intolerance in pts on suppressive regimen (limited data)

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: September 29, 2015